High 18F-FDG Uptake in a Papillary Craniopharyngioma of the Third Ventricle

Clin Nucl Med. 2023 Mar 1;48(3):245-247. doi: 10.1097/RLU.0000000000004562. Epub 2023 Jan 14.

Abstract

Craniopharyngioma is a benign tumor classified as grade 1 by the World Health Organization Classification of Tumors of the Central Nervous System. We present a rare case of a high-18F-FDG-avidity papillary craniopharyngioma of the third ventricle. A 65-year-old man underwent CT and MRI examinations for gait disturbance, lower-limb weakness, and urinary incontinence, and an oval solid tumor that extended from the suprasellar region to the third ventricle was identified. 18F-FDG PET/CT showed high accumulation (SUVmax, 22.3) in the tumor. A transventricular endoscopic tumor biopsy led to the diagnosis of papillary craniopharyngioma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Craniopharyngioma* / diagnostic imaging
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Pituitary Neoplasms* / diagnostic imaging
  • Positron Emission Tomography Computed Tomography
  • Radiopharmaceuticals
  • Third Ventricle*

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals